Literature DB >> 20171144

Lacosamide intoxication in attempted suicide.

Sebastian Bauer1, G David Rudd, Veit Mylius, Hajo M Hamer, Felix Rosenow.   

Abstract

The anticonvulsant drug lacosamide selectively enhances slow inactivation of voltage-gated sodium channels and has been shown to be an effective add-on treatment for partial-onset seizures. Common adverse events (frequency 10%) of lacosamide doses up to 600 mg/day include nonspecific central nervous system effects (e.g., dizziness, ataxia, diplopia, and somnolence). There are no human data regarding the safety of very high dosages of lacosamide. We report the clinical course of a patient with bitemporal epilepsy who ingested 12 g of lacosamide, 56 g of gabapentin, 2g of topiramate, and 2.8 g of zonisamide during a suicide attempt. The patient was found comatose and experienced repeated generalized tonic-clonic seizures, aspiration with subsequent pneumonia, hypotension, and an increase in PR interval. Complete physical recovery occurred after several days of supportive treatment. We conclude that intoxication with lacosamide, in combination with overdoses of multiple AEDs, can be survived without sequelae, even after ingestion of 12 g lacosamide. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20171144     DOI: 10.1016/j.yebeh.2010.01.007

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  7 in total

Review 1.  Novel medications for epilepsy.

Authors:  Cinzia Fattore; Emilio Perucca
Journal:  Drugs       Date:  2011-11-12       Impact factor: 9.546

2.  Lacosamide: a Study of Exposures Reported to US Poison Centers over a 9-Year Period.

Authors:  John Teijido; Derek Kempf; Elizabeth Laubach; Amy Zosel; Douglas Borys
Journal:  J Med Toxicol       Date:  2019-07-08

Review 3.  The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.

Authors:  Paul LaPenna; Laura M Tormoehlen
Journal:  J Med Toxicol       Date:  2017-08-16

Review 4.  The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience.

Authors:  Sebastian Bauer; Laurent M Willems; Esther Paule; Christine Petschow; Johann Philipp Zöllner; Felix Rosenow; Adam Strzelczyk
Journal:  Ther Adv Neurol Disord       Date:  2016-11-29       Impact factor: 6.570

5.  Lacosamide poisoning improved by hemodialysis.

Authors:  Hiroki Takahashi; Takashi Muroya; Yasutaka Okamoto; Keisuke Tamagaki; Kenji Maeshima; Atsunori Onoe; Fumiko Nakamura; Mari Nakajima; Kazuhito Sakuramoto; Kentarou Kajino; Hitoshi Ikegawa; Yasuyuki Kuwagata
Journal:  Acute Med Surg       Date:  2022-08-01

6.  Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain.

Authors:  Carlos Casas-Fernández; Antonio Martínez-Bermejo; Miguel Rufo-Campos; Patricia Smeyers-Durá; José L Herranz-Fernández; Salvador Ibáñez-Micó; Jaume Campistol-Plana; Helena Alarcón-Martínez; Jaime Campos-Castelló
Journal:  Drugs R D       Date:  2012-12-01

Review 7.  New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs).

Authors:  Karina Sommerfeld-Klatta; Barbara Zielińska-Psuja; Marta Karaźniewcz-Łada; Franciszek K Główka
Journal:  Molecules       Date:  2020-11-02       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.